The FOXO4-DRI peptide belongs to the Forkhead box O (FOXO) family of transcription factors and offers promising applications in combating senescence and age-related diseases. This peptide operates by specifically interfering with the interaction between FOXO4 and p53 – two proteins that play essential roles in cell cycle regulation and apoptosis.
Showing all 3 results
[1] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC5556182/
[2] https://pubmed.ncbi.nlm.nih.gov/26657143/
[3] https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC7053614/
[4] https://pubmed.ncbi.nlm.nih.gov/26657143/
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Peptides website: https://europe.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States